|
|
|
Volumn 43, Issue 12, 2002, Pages 1728-1729
|
|
Clinical impact of 18F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative 131I scanning results after therapy [3] (multiple leters)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUORODEOXYGLUCOSE F 18;
IODINE 131;
THYROGLOBULIN;
CANCER RECURRENCE;
CANCER SURGERY;
CANCER SURVIVAL;
CERVICAL LYMPH NODE;
DIAGNOSTIC VALUE;
HEALTH CARE COST;
HUMAN;
LETTER;
LONGEVITY;
METASTASIS;
PATIENT MONITORING;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
PROGNOSIS;
QUALITY OF LIFE;
SURVIVAL TIME;
THYROGLOBULIN BLOOD LEVEL;
THYROID CARCINOMA;
CARCINOMA;
FLUORODEOXYGLUCOSE F18;
HUMANS;
IODINE RADIOISOTOPES;
RADIOPHARMACEUTICALS;
THYROGLOBULIN;
THYROID NEOPLASMS;
TOMOGRAPHY, EMISSION-COMPUTED;
|
|
EID: 0036897556
PISSN: 01615505
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (4)
|
|
References (0)
|
